Acs Pharmacology & Translational Science

acs Pharmacology & Translational Science Publishes High Quality, Innovative, And Impactful Research Across The Broad Spectrum Of Biological Sciences, Covering Basic And Molecular Sciences Through To Translational Preclinical Studies. Clinical Studies That Address Novel Mechanisms Of Action, And Methodological Papers That Provide Innovation, And Advance Translation, Will Also Be Considered. We Give Priority To Studies That Fully Integrate Basic Pharmacological And/or Biochemical Findings Into Physiological Processes That Have Translational Potential In A Broad Range Of Biomedical Disciplines. Therefore, Studies That Employ A Complementary Blend Of In Vitro And In Vivo Systems Are Of Particular Interest To The Journal. Nonetheless, All Innovative And Impactful Research That Has An Articulated Translational Relevance Will Be Considered.

《美国药理学与转化科学学会》发表涵盖广泛生物科学领域的高质量、创新且有影响力的研究，涵盖基础和分子科学直至转化临床前研究。涉及新作用机制的临床研究以及提供创新和先进转化的方法论文也将受到考虑。我们优先考虑将基础药理学和/或生化发现完全整合到生理过程的研究，这些研究在广泛的生物医学学科中具有转化潜力。因此，采用体外和体内系统互补混合的研究对期刊特别有吸引力。尽管如此，所有具有明确转化相关性的创新且有影响力的研究都将被考虑。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映Medicine-Pharmacology (medical)领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为4.9，平均审稿速度为 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。